Fexofenadine

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

78 Suppliers, 25 USDMF, 12 CEP/COS, 16 JDMF, 12 EU WC, 8 KDMF, 24 NDC API, 46 Listed Suppliers

DEVELOPMENTS

4 Drug(s) in Development

4 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

INTERMEDIATES

24 Suppliers

24 Suppliers

DOSSIERs // Finished Dosage Forms

223 Dossiers, 96 FDA Orange Book, 37 Europe, 4 Canada, 5 Australia, 24 South Africa, 57 Listed Dossiers

DRUG PRODUCT COMPOSITION

SUSPENSION;ORAL - 30MG/5ML, TABLET, EXTENDED RELEASE;ORAL - 60MG;120MG, TABLET;ORAL - 180MG, TABLET;ORAL - 30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 60MG, TABLET, EXTENDED RELEASE;ORAL - 180MG;240MG, TABLET, ORALLY DISINTEGRATING;ORAL - 30MG, SUSPENSION;ORAL - 30MG/5ML

RELATED EXCIPIENT COMPANIES

Suppliers, 37 Kerry, 36 BASF, 29 Roquette, 18 Microlex e.U, 18 SPI Pharma, 13 Seppic, 13 Gangwal Healthcare, 12 Actylis, 12 Sigachi Industries, 12 Gangwal Chemicals, 11 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 11 Corel Pharma Chem, 8 Boai NKY Pharmaceuticals Ltd, 8 Nanjing Well Pharmaceutical, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 7 DFE Pharma, 6 Rochem International Inc, 6 Lonza Capsugel, 5 Ideal Cures Pvt Ltd, 5 Ingredion Pharma Solutions, 5 Prachin Chemical, 5 Pharmatrans-Sanaq, 4 Vasa Pharmachem, 4 ACG Worldwide, 4 Kima Chemical, 3 Jai Radhe Sales, 3 DKSH, 3 Alcedo Pharmachem, 3 The Dow Chemical Company, 3 Ulanqab Kema New Material, 2 Pfanstiehl, 2 Pharm-RX Chemical, 2 Nanjing Bold Chemical, 2 Qualicaps, 2 Nomisma Healthcare, 2 Zhejiang Huakang Pharmaceutical, 2 Seqens, 2 Finar, 2 Vertellus, 1 Clariant, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Bioplus Life Sciences, 1 NEWEDGE Overseas, 1 Chynops Pharma, 1 Minakem, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Aeon Procare, 1 Huzhou Sunflower Pharmaceutical Co. Ltd

EXCIPIENTS BY APPLICATIONS

102 Fillers, Diluents & Binders, 58 Coating Systems & Additives, 50 Direct Compression, 44 Disintegrants & Superdisintegrants, 36 Thickeners and Stabilizers, 36 Controlled & Modified Release, 35 Granulation, 32 Taste Masking, 31 Solubilizers, 27 Lubricants & Glidants, 26 Film Formers & Plasticizers, 23 Chewable & Orodispersible Aids, 19 Topical, 19 Parenteral, 17 Co-Processed Excipients, 9 Empty Capsules, 9 API Stability Enhancers, 6 Emulsifying Agents, 5 Rheology Modifiers, 4 Vegetarian Capsules, 4 Surfactant & Foaming Agents, 2 Coloring Agents

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 35 Finished Drug Prices

MARKET PLACE

32 APIs, 2 DOSSIERS // FDF

PATENTS

2 US Patents, 14 Health Canada Patents

ANALYTICAL SOLUTION(s)

1 BioAnalytical Methods, 5 Analytical Solutions, 4 EDQM Standards, 3 USP Standards, 4 JP Standards, 6 Other Ref. Standards

DIGITAL CONTENT

4 Data Compilation & Company Tracker #PharmaFlow, 28 News

Latest U.S. Prescription Data for Drugs containing Fexofenadine under Medicare's Part D Prescription Drug Program. Original Data: Centers for Medicare & Medicaid Services Website

Fexofenadine

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

78 Suppliers

25 USDMF

12 CEP/COS

16 JDMF

12 EU WC

8 KDMF

24 NDC API

46 Listed Suppliers

DEVELOPMENTS

4 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Exports

FDF Imports

INTERMEDIATES

24 Suppliers

DOSSIERs // Finished Dosage Forms

223 Dossiers

96 FDA Orange Book

37 Europe

4 Canada

5 Australia

24 South Africa

57 Listed Dossiers

DRUG PRODUCT COMPOSITION

SUSPENSION;ORAL - 30MG/5ML

TABLET, EXTENDED RELEASE;ORAL - 60MG;120MG

TABLET;ORAL - 180MG

TABLET;ORAL - 30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 60MG

TABLET, EXTENDED RELEASE;ORAL - 180MG;240MG

TABLET, ORALLY DISINTEGRATING;ORAL - 30MG

SUSPENSION;ORAL - 30MG/5ML

RELATED EXCIPIENT COMPANIES

Suppliers

37 Kerry

36 BASF

29 Roquette

18 Microlex e.U

18 SPI Pharma

13 Seppic

13 Gangwal Healthcare

12 Actylis

12 Sigachi Industries

12 Gangwal Chemicals

11 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

11 Corel Pharma Chem

8 Boai NKY Pharmaceuticals Ltd

8 Nanjing Well Pharmaceutical

7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

7 DFE Pharma

6 Rochem International Inc

6 Lonza Capsugel

5 Ideal Cures Pvt Ltd

5 Ingredion Pharma Solutions

5 Prachin Chemical

5 Pharmatrans-Sanaq

4 Vasa Pharmachem

4 ACG Worldwide

4 Kima Chemical

3 Jai Radhe Sales

3 DKSH

3 Alcedo Pharmachem

3 The Dow Chemical Company

3 Ulanqab Kema New Material

2 Pfanstiehl

2 Pharm-RX Chemical

2 Nanjing Bold Chemical

2 Qualicaps

2 Nomisma Healthcare

2 Zhejiang Huakang Pharmaceutical

2 Seqens

2 Finar

TABLET;ORAL - 30MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons